Colorectal Liver Metastases Clinical Trial
Official title:
Randomised Controlled Phase I/II Trail to Evaluate the Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation Therapy in Resectable Colorectal Liver Metastases Patients
The efficiency of T cell based immunotherapies is affected by the insufficient migration and
activity of tumor specific effector T cells in the tumor. Aim of this phase I/II clinical
trial is to evaluate whether a neoadjuvant, low dose radiotherapy can improve T cell
connected anti tumor immune response in colorectal liver metastases.
The primary endpoint is the number of tumor infiltrating T cells. Furthermore the T cell
activity in situ, the number of regulatory T cells and the frequency of tumor reactive T
cells in the blood and bone marrow will be examined.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01255007 -
Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases
|
N/A | |
Completed |
NCT00779272 -
Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver Metastases
|
N/A | |
Active, not recruiting |
NCT00797251 -
Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression
|
N/A | |
Recruiting |
NCT06045286 -
High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM
|
Phase 1 | |
Recruiting |
NCT04870879 -
Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors
|
N/A | |
Completed |
NCT01799044 -
Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver Metastases
|
Phase 1 | |
Terminated |
NCT00508872 -
Folfox-B Study for Patients With Colorectal Liver Metastases
|
Phase 2 | |
Recruiting |
NCT05877001 -
The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases
|
Phase 2 | |
Completed |
NCT02082782 -
Efficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver Metastases
|
Phase 2 | |
Completed |
NCT00942292 -
The Effect of Fish Oils on Human Hepatic Colorectal Metastases
|
Phase 2 | |
Completed |
NCT00119899 -
Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases
|
Phase 3 | |
Completed |
NCT00184834 -
Quality of Life and Liver Metastases
|
N/A | |
Completed |
NCT00557557 -
Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
|
Phase 1 | |
Recruiting |
NCT05468593 -
Patient Outcomes After Hepatic Artery Infusion Pump Placement
|
||
Completed |
NCT02615665 -
Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases
|
N/A | |
Terminated |
NCT01318447 -
CyberKnife® for Hepatic Metastases From Colorectal Cancer
|
Phase 2 | |
Completed |
NCT00885950 -
Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants
|
N/A | |
Completed |
NCT02331641 -
Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases.
|
N/A | |
Completed |
NCT00600522 -
Alternative Surgical Policy for Central Liver Tumors
|
N/A | |
Recruiting |
NCT05265169 -
Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)
|
N/A |